Celanese Corporation
General ticker "CE" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $5.5B (TTM average)
Celanese Corporation follows the US Stock Market performance with the rate: 15.6%.
Estimated limits based on current volatility of 1.7%: low 46.00$, high 47.63$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-04-27, amount 0.03$ (Y0.26%)
- Total employees count: 11434 (-6.0%) as of 2025
- China accounted for 19.3% of revenue in the fiscal year ended 2024-12-31
- US accounted for 26.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Raw material costs, Supply chain disruptions, Regulatory and compliance, Cybersecurity threats
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [26.85$, 50.45$]
- 2026-12-31 to 2027-12-31 estimated range: [30.92$, 55.24$]
Financial Metrics affecting the CE estimates:
- Negative: with PPE of 10.6 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 24.66 > 12.93
- Positive: 7.57 < Operating profit margin, % of 8.04
- Positive: Industry operating cash flow per share per price (median), % of 12.71 > 10.32
- Positive: Inventory ratio change, % of 0.69 <= 0.80
- Negative: Investing cash flow per share per price, % of -7.51 <= -4.39
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 18.66 <= 19.19
- Negative: Industry inventory ratio change (median), % of 1.38 > 0.28
Short-term CE quotes
Long-term CE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $10,940.00MM | $10,280.00MM | $9,544.00MM |
| Operating Expenses | $9,253.00MM | $10,977.00MM | $8,777.00MM |
| Operating Income | $1,687.00MM | $-697.00MM | $767.00MM |
| Non-Operating Income | $-504.00MM | $-299.00MM | $-1,987.00MM |
| Interest Expense | $720.00MM | $676.00MM | $769.00MM |
| R&D Expense | $146.00MM | $130.00MM | $125.00MM |
| Income(Loss) | $1,183.00MM | $-996.00MM | $-1,220.00MM |
| Taxes | $-790.00MM | $510.00MM | $-90.00MM |
| Net Income(Loss)* | $1,960.00MM | $-1,522.00MM | $-1,165.00MM |
| Stockholders Equity | $7,091.00MM | $5,175.00MM | $4,049.00MM |
| Inventory | $2,357.00MM | $2,284.00MM | $2,220.00MM |
| Assets | $26,597.00MM | $22,857.00MM | $21,695.00MM |
| Operating Cash Flow | $1,899.00MM | $966.00MM | $1,146.00MM |
| Capital expenditure | $568.00MM | $435.00MM | $343.00MM |
| Investing Cash Flow | $-134.00MM | $-470.00MM | $-349.00MM |
| Financing Cash Flow | $-1,456.00MM | $-1,313.00MM | $-513.00MM |
| Earnings Per Share** | $18.01 | $-13.93 | $-10.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.